West Pharmaceutical Services, Inc.WSTNYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank64
3Y CAGR-5.6%
5Y CAGR-0.5%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-5.6%/yr
vs +8.0%/yr prior
5Y CAGR
-0.5%/yr
Recent deceleration
Acceleration
-13.7pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 23.54% | -8.4% |
| 2024 | 25.71% | -10.1% |
| 2023 | 28.60% | +2.1% |
| 2022 | 28.01% | -9.9% |
| 2021 | 31.08% | +28.6% |
| 2020 | 24.17% | +10.5% |
| 2019 | 21.87% | +6.4% |
| 2018 | 20.56% | +0.9% |
| 2017 | 20.38% | +7.2% |
| 2016 | 19.01% | - |